Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse”

Detalles Bibliográficos
Autores principales: Guo, Yafei, Wang, Lingan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333002/
https://www.ncbi.nlm.nih.gov/pubmed/30713836
http://dx.doi.org/10.1155/2019/4927083
_version_ 1783387480310939648
author Guo, Yafei
Wang, Lingan
author_facet Guo, Yafei
Wang, Lingan
author_sort Guo, Yafei
collection PubMed
description
format Online
Article
Text
id pubmed-6333002
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-63330022019-02-03 Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse” Guo, Yafei Wang, Lingan Can J Gastroenterol Hepatol Letter to the Editor Hindawi 2019-01-01 /pmc/articles/PMC6333002/ /pubmed/30713836 http://dx.doi.org/10.1155/2019/4927083 Text en Copyright © 2019 Yafei Guo and Lingan Wang. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Guo, Yafei
Wang, Lingan
Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse”
title Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse”
title_full Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse”
title_fullStr Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse”
title_full_unstemmed Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse”
title_short Comment on “48-Week Outcome after Cessation of Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Patient and the Associated Factors with Relapse”
title_sort comment on “48-week outcome after cessation of nucleos(t)ide analogue treatment in chronic hepatitis b patient and the associated factors with relapse”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6333002/
https://www.ncbi.nlm.nih.gov/pubmed/30713836
http://dx.doi.org/10.1155/2019/4927083
work_keys_str_mv AT guoyafei commenton48weekoutcomeaftercessationofnucleostideanaloguetreatmentinchronichepatitisbpatientandtheassociatedfactorswithrelapse
AT wanglingan commenton48weekoutcomeaftercessationofnucleostideanaloguetreatmentinchronichepatitisbpatientandtheassociatedfactorswithrelapse

Ejemplares similares